TY - STD TI - SEER Stat Fact Sheets: Bladder Cancer [http://seer.cancer.gov/statfacts/html/urinb.html]. UR - http://seer.cancer.gov/statfacts/html/urinb.html ID - ref1 ER - TY - STD TI - Mayo Clinic. Diseases and conditions: bladder cancer [http://www.mayoclinic.org/diseases-conditions/bladder-cancer/basics/risk-factors/con-20027606]. UR - http://www.mayoclinic.org/diseases-conditions/bladder-cancer/basics/risk-factors/con-20027606 ID - ref2 ER - TY - JOUR AU - Kaufman, D. S. AU - Shipley, W. U. AU - Feldman, A. S. PY - 2009 DA - 2009// TI - Bladder cancer JO - Lancet VL - 374 UR - https://doi.org/10.1016/S0140-6736(09)60491-8 DO - 10.1016/S0140-6736(09)60491-8 ID - Kaufman2009 ER - TY - STD TI - Bladder Cancer Staging [http://www.cancer.org/cancer/bladdercancer/detailedguide/bladder-cancer-staging]. UR - http://www.cancer.org/cancer/bladdercancer/detailedguide/bladder-cancer-staging ID - ref4 ER - TY - JOUR AU - Freedman, N. D. AU - Silverman, D. T. AU - Hollenbeck, A. R. AU - Schatzkin, A. AU - Abnet, C. C. PY - 2011 DA - 2011// TI - Association between smoking and risk of bladder cancer among men and women JO - JAMA VL - 306 UR - https://doi.org/10.1001/jama.2011.1142 DO - 10.1001/jama.2011.1142 ID - Freedman2011 ER - TY - JOUR AU - Solsona, E. AU - Iborra, I. AU - Ricos, J. V. AU - Monros, J. L. AU - Casanova, J. AU - Dumont, R. PY - 1999 DA - 1999// TI - Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup JO - J Urol VL - 161 UR - https://doi.org/10.1016/S0022-5347(01)61606-9 DO - 10.1016/S0022-5347(01)61606-9 ID - Solsona1999 ER - TY - JOUR AU - Ali-el-Dein, B. AU - Nabeeh, A. AU - el-Baz, M. AU - Shamaa, S. AU - Ashamallah, A. PY - 1997 DA - 1997// TI - Single-dose versus multiple instillations of epirubicin as prophylaxis for recurrence after transurethral resection of pTa and pT1 transitional-cell bladder tumours: a prospective, randomized controlled study JO - Br J Urol VL - 79 UR - https://doi.org/10.1046/j.1464-410X.1997.00142.x DO - 10.1046/j.1464-410X.1997.00142.x ID - Ali-el-Dein1997 ER - TY - JOUR AU - Lamm, D. L. AU - Blumenstein, B. A. AU - Crawford, E. D. AU - Montie, J. E. AU - Scardino, P. AU - Grossman, H. B. PY - 1991 DA - 1991// TI - A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guerin for transitional-cell carcinoma of the bladder JO - N Engl J Med VL - 325 UR - https://doi.org/10.1056/NEJM199110243251703 DO - 10.1056/NEJM199110243251703 ID - Lamm1991 ER - TY - JOUR AU - Herr, H. W. AU - Schwalb, D. M. AU - Zhang, Z. F. AU - Sogani, P. C. AU - Fair, W. R. AU - Whitmore, W. F. PY - 1995 DA - 1995// TI - Intravesical bacillus Calmette-Guerin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial JO - J Clin Oncol VL - 13 ID - Herr1995 ER - TY - STD TI - Chemotherapy for bladder cancer [http://www.cancer.org/cancer/bladdercancer/detailedguide/bladder-cancer-treating-chemotherapy]. UR - http://www.cancer.org/cancer/bladdercancer/detailedguide/bladder-cancer-treating-chemotherapy ID - ref10 ER - TY - JOUR AU - Keizer, H. G. AU - Pinedo, H. M. AU - Schuurhuis, G. J. AU - Joenje, H. PY - 1990 DA - 1990// TI - Doxorubicin (adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicity JO - Pharmacol Ther VL - 47 UR - https://doi.org/10.1016/0163-7258(90)90088-J DO - 10.1016/0163-7258(90)90088-J ID - Keizer1990 ER - TY - JOUR AU - Bodley, A. AU - Liu, L. F. AU - Israel, M. AU - Seshadri, R. AU - Koseki, Y. AU - Giuliani, F. C. PY - 1989 DA - 1989// TI - DNA Topoisomerase II-mediated Interaction of Doxorubicin and Daunorubicin Congeners with DNA JO - Cancer Res VL - 49 ID - Bodley1989 ER - TY - JOUR AU - Wassermann, K. AU - Markovits, J. AU - Jaxel, C. AU - Capranico, G. AU - Kohn, K. W. AU - Pommier, Y. PY - 1990 DA - 1990// TI - Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II JO - Mol Pharmacol VL - 38 ID - Wassermann1990 ER - TY - JOUR AU - Capranico, G. AU - Kohn, K. W. AU - Pommier, Y. PY - 1990 DA - 1990// TI - Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicin JO - Nucleic Acids Res VL - 18 UR - https://doi.org/10.1093/nar/18.22.6611 DO - 10.1093/nar/18.22.6611 ID - Capranico1990 ER - TY - JOUR AU - Mizutani, H. AU - Tada-Oikawa, S. AU - Hiraku, Y. AU - Kojima, M. AU - Kawanishi, S. PY - 2005 DA - 2005// TI - Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide JO - Life Sci VL - 76 UR - https://doi.org/10.1016/j.lfs.2004.05.040 DO - 10.1016/j.lfs.2004.05.040 ID - Mizutani2005 ER - TY - JOUR AU - Wang, S. AU - Konorev, E. A. AU - Kotamraju, S. AU - Joseph, J. AU - Kalivendi, S. AU - Kalyanaraman, B. PY - 2004 DA - 2004// TI - Doxorubicin Induces apoptosis in normal and tumor cells via distinctly different mechanisms: intermediacy of H2O2- and p53-dependent pathways JO - J Biol Chem VL - 279 UR - https://doi.org/10.1074/jbc.M400944200 DO - 10.1074/jbc.M400944200 ID - Wang2004 ER - TY - JOUR AU - Tsang, W. P. AU - Chau, S. P. Y. AU - Kong, S. K. AU - Fung, K. P. AU - Kwok, T. T. PY - 2003 DA - 2003// TI - Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis JO - Life Sci VL - 73 UR - https://doi.org/10.1016/S0024-3205(03)00566-6 DO - 10.1016/S0024-3205(03)00566-6 ID - Tsang2003 ER - TY - JOUR AU - Dalton, W. S. AU - Grogan, T. M. AU - Meltzer, P. S. AU - Scheper, R. J. AU - Durie, B. G. AU - Taylor, C. W. PY - 1989 DA - 1989// TI - Drug-resistance in multiple myeloma and non-Hodgkin’s lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy JO - J Clin Oncol VL - 7 ID - Dalton1989 ER - TY - JOUR AU - Gottesman, M. M. PY - 2002 DA - 2002// TI - Mechanisms of cancer drug resistance JO - Annu Rev Med VL - 53 UR - https://doi.org/10.1146/annurev.med.53.082901.103929 DO - 10.1146/annurev.med.53.082901.103929 ID - Gottesman2002 ER - TY - JOUR AU - Frishman, W. H. AU - Sung, H. M. AU - Yee, H. C. M. AU - Liu, L. L. AU - Einzig, A. I. AU - Dutcher, J. PY - 1996 DA - 1996// TI - Cardiovascular toxicity with cancer chemotherapy JO - Curr Probl Cardiol VL - 21 UR - https://doi.org/10.1016/S0146-2806(96)80011-9 DO - 10.1016/S0146-2806(96)80011-9 ID - Frishman1996 ER - TY - JOUR AU - Lothstein, L. AU - Wright, H. M. AU - Sweatman, T. W. AU - Israel, M. PY - 1992 DA - 1992// TI - N-benzyladriamycin-14-valerate and drug resistance: correlation of anthracycline structural modification with intracellular accumulation and distribution in multidrug resistant cells JO - Oncol Res VL - 4 ID - Lothstein1992 ER - TY - JOUR AU - Lothstein, L. AU - Savranskaya, L. AU - Barrett, C. M. AU - Israel, M. AU - Sweatman, T. W. PY - 2006 DA - 2006// TI - N-benzyladriamycin-14-valerate (AD 198) activates protein kinase C-delta holoenzyme to trigger mitochondrial depolarization and cytochrome c release independently of permeability transition pore opening and Ca2+ influx JO - Anticancer Drugs VL - 17 UR - https://doi.org/10.1097/00001813-200606000-00002 DO - 10.1097/00001813-200606000-00002 ID - Lothstein2006 ER - TY - JOUR AU - Hofmann, P. A. AU - Israel, M. AU - Koseki, Y. AU - Laskin, J. AU - Gray, J. AU - Janik, A. PY - 2007 DA - 2007// TI - N-Benzyladriamycin-14-valerate (AD 198): a non-cardiotoxic anthracycline that is cardioprotective through PKC-ε activation JO - J Pharmacol Exp Ther VL - 323 UR - https://doi.org/10.1124/jpet.107.126110 DO - 10.1124/jpet.107.126110 ID - Hofmann2007 ER - TY - JOUR AU - Edwards, S. K. AU - Moore, C. R. AU - Liu, Y. AU - Grewal, S. AU - Covey, L. R. AU - Xie, P. PY - 2013 DA - 2013// TI - N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma JO - BMC Cancer VL - 13 UR - https://doi.org/10.1186/1471-2407-13-481 DO - 10.1186/1471-2407-13-481 ID - Edwards2013 ER - TY - JOUR AU - Rathore, K. AU - Cekanova, M. PY - 2015 DA - 2015// TI - A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro JO - J Drug Des Dev Ther VL - 2015 ID - Rathore2015 ER - TY - JOUR AU - Sweatman, T. W. AU - Seshadri, R. AU - Israel, M. PY - 1999 DA - 1999// TI - Pharmacology of N-benzyladriamycin-14-valerate in the rat JO - Cancer Chemother Pharmacol VL - 43 UR - https://doi.org/10.1007/s002800050917 DO - 10.1007/s002800050917 ID - Sweatman1999 ER - TY - JOUR AU - Cai, C. AU - Lothstein, L. AU - Morrison, R. R. AU - Hofmann, P. A. PY - 2010 DA - 2010// TI - Protection from doxorubicin-induced cardiomyopathy using the modified anthracycline N-benzyladriamycin-14-valerate (AD 198) JO - J Pharmacol Exp Ther VL - 335 UR - https://doi.org/10.1124/jpet.110.167965 DO - 10.1124/jpet.110.167965 ID - Cai2010 ER - TY - JOUR AU - Duriez, P. AU - Shah, G. M. PY - 1997 DA - 1997// TI - Cleavage of poly (ADP-ribose) polymerase: a sensitive parameter to study cell death JO - Biochem Cell Biol VL - 75 UR - https://doi.org/10.1139/o97-043 DO - 10.1139/o97-043 ID - Duriez1997 ER - TY - JOUR AU - Soldani, C. AU - Scovassi, A. PY - 2002 DA - 2002// TI - Poly (ADP-ribose) polymerase-1 cleavage during apoptosis: an update JO - Apoptosis VL - 7 UR - https://doi.org/10.1023/A:1016119328968 DO - 10.1023/A:1016119328968 ID - Soldani2002 ER - TY - JOUR AU - Franke, T. F. AU - Kaplan, D. R. AU - Cantley, L. C. PY - 1997 DA - 1997// TI - PI3K: downstream AKTion blocks apoptosis JO - Cell VL - 88 UR - https://doi.org/10.1016/S0092-8674(00)81883-8 DO - 10.1016/S0092-8674(00)81883-8 ID - Franke1997 ER - TY - JOUR AU - Wold, L. E. AU - Aberle, N. S. AU - Ren, J. PY - 2005 DA - 2005// TI - Doxorubicin induces cardiomyocyte dysfunction via a p38 MAP kinase-dependent oxidative stress mechanism JO - Cancer Detect Prev VL - 29 UR - https://doi.org/10.1016/j.cdp.2004.07.008 DO - 10.1016/j.cdp.2004.07.008 ID - Wold2005 ER - TY - JOUR AU - Deng, Y. T. AU - Huang, H. C. AU - Lin, J. K. PY - 2010 DA - 2010// TI - Rotenone induces apoptosis in MCF‐7 human breast cancer cell‐mediated ROS through JNK and p38 signaling JO - Mol Carcinog VL - 49 ID - Deng2010 ER - TY - JOUR AU - Garnick, M. B. AU - Schade, D. AU - Israel, M. AU - Maxwell, B. AU - Richie, J. P. PY - 1984 DA - 1984// TI - Intravesical doxorubicin for prophylaxis in the management of recurrent superficial bladder carcinoma JO - J Urol VL - 131 ID - Garnick1984 ER - TY - JOUR AU - Chen, C. -. H. AU - Yang, H. -. J. AU - Shun, C. -. T. AU - Huang, C. -. Y. AU - Huang, K. -. H. AU - Yu, H. -. J. PY - 2012 DA - 2012// TI - A cocktail regimen of intravesical mitomycin-C, doxorubicin, and cisplatin (MDP) for non-muscle-invasive bladder cancer JO - Urol Oncol VL - 30 UR - https://doi.org/10.1016/j.urolonc.2010.06.012 DO - 10.1016/j.urolonc.2010.06.012 ID - Chen2012 ER - TY - JOUR AU - Kimiya, K. AU - Naito, S. AU - Soejima, T. AU - Sakamoto, N. AU - Kotoh, S. AU - Kumazawa, J. PY - 1992 DA - 1992// TI - Establishment and characterization of doxorubicin-resistant human bladder cancer cell line, KK47/ADM JO - J Urol VL - 148 ID - Kimiya1992 ER - TY - JOUR AU - Lothstein, L. AU - Israel, M. AU - Sweatman, T. W. PY - 2001 DA - 2001// TI - Anthracycline drug targeting: cytoplasmic versus nuclear–a fork in the road JO - Drug Resist Updat VL - 4 UR - https://doi.org/10.1054/drup.2001.0201 DO - 10.1054/drup.2001.0201 ID - Lothstein2001 ER - TY - JOUR AU - Ganapathi, R. AU - Grabowski, D. AU - Sweatman, T. W. AU - Seshadri, R. AU - Israel, M. PY - 1989 DA - 1989// TI - N-benzyladriamycin-14-valerate versus progressively doxorubicin-resistant murine tumours: cellular pharmacology and characterisation of cross-resistance in vitro and in vivo JO - Br J Cancer VL - 60 UR - https://doi.org/10.1038/bjc.1989.373 DO - 10.1038/bjc.1989.373 ID - Ganapathi1989 ER - TY - JOUR AU - Lothstein, L. AU - Savranskaya, L. AU - Sweatman, T. W. PY - 2007 DA - 2007// TI - N-Benzyladriamycin-14-valerate (AD 198) cytotoxicty circumvents Bcr-Abl anti-apoptotic signaling in human leukemia cells and also potentiates imatinib cytotoxicity JO - Leuk Res VL - 31 UR - https://doi.org/10.1016/j.leukres.2006.11.003 DO - 10.1016/j.leukres.2006.11.003 ID - Lothstein2007 ER - TY - JOUR AU - Harstrick, A. AU - Vanhoefer, U. AU - Schieucher, N. AU - Schroeder, J. AU - Baumgart, J. AU - Scheulen, M. PY - 1995 DA - 1995// TI - Activity of N-benzyl-adriamycin-14-valerate (AD198), a new anthracycline derivate, in multidrug resistant human ovarian and breast carcinoma cell lines JO - Anticancer Drugs VL - 6 UR - https://doi.org/10.1097/00001813-199510000-00007 DO - 10.1097/00001813-199510000-00007 ID - Harstrick1995 ER - TY - JOUR AU - Lothstein, L. AU - Wright, H. AU - Sweatman, T. AU - Israel, M. PY - 1991 DA - 1991// TI - N-benzyladriamycin-14-valerate and drug resistance: correlation of anthracycline structural modification with intracellular accumulation and distribution in multidrug resistant cells JO - Oncol Res VL - 4 ID - Lothstein1991 ER - TY - JOUR AU - Gamen, S. AU - Anel, A. AU - Lasierra, P. AU - Alava, M. A. AU - Martinez-Lorenzo, M. J. AU - Piñeiro, A. PY - 1997 DA - 1997// TI - Doxorubicin-induced apoptosis in human T-cell leukemia is mediated by caspase-3 activation in a Fas-independent way JO - FEBS Lett VL - 417 UR - https://doi.org/10.1016/S0014-5793(97)01282-9 DO - 10.1016/S0014-5793(97)01282-9 ID - Gamen1997 ER - TY - JOUR AU - Bernuzzi, F. AU - Recalcati, S. AU - Alberghini, A. AU - Cairo, G. PY - 2009 DA - 2009// TI - Reactive oxygen species-independent apoptosis in doxorubicin-treated H9c2 cardiomyocytes: role for heme oxygenase-1 down-modulation JO - Chem Biol Interact VL - 177 UR - https://doi.org/10.1016/j.cbi.2008.09.012 DO - 10.1016/j.cbi.2008.09.012 ID - Bernuzzi2009 ER - TY - JOUR AU - McCubrey, J. A. AU - Steelman, L. S. AU - Abrams, S. L. AU - Lee, J. T. AU - Chang, F. AU - Bertrand, F. E. PY - 2006 DA - 2006// TI - Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance JO - Adv Enzyme Regul VL - 46 UR - https://doi.org/10.1016/j.advenzreg.2006.01.004 DO - 10.1016/j.advenzreg.2006.01.004 ID - McCubrey2006 ER - TY - JOUR AU - Misra, S. AU - Ghatak, S. AU - Toole, B. P. PY - 2005 DA - 2005// TI - Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2 JO - J Biol Chem VL - 280 UR - https://doi.org/10.1074/jbc.M500737200 DO - 10.1074/jbc.M500737200 ID - Misra2005 ER - TY - JOUR AU - Bezler, M. AU - Hengstler, J. G. AU - Ullrich, A. PY - 2012 DA - 2012// TI - Inhibition of doxorubicin-induced HER3-PI3K-AKT signalling enhances apoptosis of ovarian cancer cells JO - Mol Oncol VL - 6 UR - https://doi.org/10.1016/j.molonc.2012.07.001 DO - 10.1016/j.molonc.2012.07.001 ID - Bezler2012 ER - TY - BOOK AU - Ghebeh, H. AU - Lehe, C. AU - Barhoush, E. AU - Al-Romaih, K. AU - Tulbah, A. AU - Al-Alwan, M. PY - 2010 DA - 2010// TI - Research article Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule ID - Ghebeh2010 ER - TY - JOUR AU - Lai, J. -. P. AU - Sandhu, D. S. AU - Moser, C. D. AU - Cazanave, S. C. AU - Oseini, A. M. AU - Shire, A. M. PY - 2009 DA - 2009// TI - Additive effect of apicidin and doxorubicin in sulfatase 1 expressing hepatocellular carcinoma in vitro and in vivo JO - J Hepatol VL - 50 UR - https://doi.org/10.1016/j.jhep.2008.12.031 DO - 10.1016/j.jhep.2008.12.031 ID - Lai2009 ER - TY - JOUR AU - Sun, C. H. AU - Chang, Y. H. AU - Pan, C. C. PY - 2011 DA - 2011// TI - Activation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder JO - Histopathology VL - 58 UR - https://doi.org/10.1111/j.1365-2559.2011.03856.x DO - 10.1111/j.1365-2559.2011.03856.x ID - Sun2011 ER - TY - JOUR AU - Network, T. C. G. A. R. PY - 2014 DA - 2014// TI - Comprehensive molecular characterization of urothelial bladder carcinoma JO - Nature VL - 507 UR - https://doi.org/10.1038/nature12965 DO - 10.1038/nature12965 ID - Network2014 ER - TY - JOUR AU - Knowles, M. A. AU - Platt, F. M. AU - Ross, R. L. AU - Hurst, C. D. PY - 2009 DA - 2009// TI - Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer JO - Cancer Metastasis Rev VL - 28 UR - https://doi.org/10.1007/s10555-009-9198-3 DO - 10.1007/s10555-009-9198-3 ID - Knowles2009 ER - TY - JOUR AU - Seront, E. AU - Pinto, A. AU - Bouzin, C. AU - Bertrand, L. AU - Machiels, J. -. P. AU - Feron, O. PY - 2013 DA - 2013// TI - PTEN deficiency is associated with reduced sensitivity to mTOR inhibitor in human bladder cancer through the unhampered feedback loop driving PI3K/Akt activation JO - Br J Cancer VL - 109 UR - https://doi.org/10.1038/bjc.2013.505 DO - 10.1038/bjc.2013.505 ID - Seront2013 ER - TY - JOUR AU - Martin-Doyle, W. AU - Kwiatkowski, D. J. PY - 2015 DA - 2015// TI - Molecular biology of bladder cancer JO - Hematol Oncol Clin North Am VL - 29 UR - https://doi.org/10.1016/j.hoc.2014.10.002 DO - 10.1016/j.hoc.2014.10.002 ID - Martin-Doyle2015 ER - TY - JOUR AU - Baldo, P. AU - Cecco, S. AU - Giacomin, E. AU - Lazzarini, R. AU - Ros, B. AU - Marastoni, S. PY - 2008 DA - 2008// TI - mTOR pathway and mTOR inhibitors as agents for cancer therapy JO - Curr Cancer Drug Targets VL - 8 UR - https://doi.org/10.2174/156800908786733513 DO - 10.2174/156800908786733513 ID - Baldo2008 ER - TY - JOUR AU - Wu, D. AU - Tao, J. AU - Xu, B. AU - Qing, W. AU - Li, P. AU - Lu, Q. PY - 2011 DA - 2011// TI - Phosphatidylinositol 3-Kinase inhibitor LY294002 suppresses proliferation and sensitizes doxorubicin chemotherapy in bladder cancer cells JO - Urol Int VL - 87 UR - https://doi.org/10.1159/000322849 DO - 10.1159/000322849 ID - Wu2011 ER - TY - JOUR AU - Saal, L. H. AU - Johansson, P. AU - Holm, K. AU - Gruvberger-Saal, S. K. AU - She, Q. -. B. AU - Maurer, M. PY - 2007 DA - 2007// TI - Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity JO - Proc Natl Acad Sci VL - 104 UR - https://doi.org/10.1073/pnas.0702507104 DO - 10.1073/pnas.0702507104 ID - Saal2007 ER - TY - JOUR AU - Tanaka, M. AU - Grossman, H. B. PY - 2003 DA - 2003// TI - In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth, downregulates phosphorylated Akt, and increases sensitivity to doxorubicin JO - Gene Ther VL - 10 UR - https://doi.org/10.1038/sj.gt.3302056 DO - 10.1038/sj.gt.3302056 ID - Tanaka2003 ER - TY - JOUR AU - Wang, D. S. AU - Rieger‐Christ, K. AU - Latini, J. M. AU - Moinzadeh, A. AU - Stoffel, J. AU - Pezza, J. A. PY - 2000 DA - 2000// TI - Molecular analysis of PTEN and MXI1 in primary bladder carcinoma JO - Int J Cancer VL - 88 UR - https://doi.org/3.0.CO;2-Z DO - 3.0.CO;2-Z ID - Wang2000 ER -